HOME >> BIOLOGY >> NEWS
Chicken genome will help our understanding of humans and improve agriculture

The first full DNA sequence of the chicken (Gallus gallus) genome is published today in the journal Nature. UK scientists have worked closely with 170 researchers from 49 institutes worldwide, to interpret the genome of the chicken. They believe it will help us to understand more about the biology of chickens and will also give us further insights into humans and fundamental biological processes.

"The sequencing of the chicken genome is a major landmark as the first agriculturally important animal to have its genome sequenced and has great implications for furthering our understanding of the human genome," said Professor David Burt of the Roslin Institute, Edinburgh, who led a Biotechnology and Biological Sciences Research Council (BBSRC) funded team which worked on the annotation of the genome within the international chicken genome project. "The chicken has also been used extensively as a model by developmental biologists for over a century and the availability of a gene catalogue for the species will boost research in this area."

From the sequencing of the human and other mammalian genomes we have a large number of genes for which the function is still a mystery. The chicken is located part way between mammals and fish in the tree of life and the sequenced genome will help us to understand the function of human genes and the way that they have evolved in vertebrates.

Scientists at the BBSRC-sponsored Institute for Animal Health (IAH) in Compton, Berkshire, have analysed the part of the chicken genome responsible for controlling tissue rejection and which influences the susceptibility of individuals to diseases. Their work, led by Dr Jim Kaufman, will aid the breeding of healthier chickens and the design of better veterinary vaccines.

Analysis of the sequence has revealed how similar the arrangement of genes in the chicken and human genomes are - at a basic level this comparison is even better than the mouse, a common model
'"/>

Contact: Matt Goode
matt.goode@bbsrc.ac.uk
44-179-341-3299
Biotechnology and Biological Sciences Research Council
8-Dec-2004


Page: 1 2

Related biology news :

1. Chickens dieting to help Delaware waterways
2. Chickens also orient themselves by the Earths magnetic field
3. Chickens orient using a magnetic compass
4. Chicken genome analysis will benefit human health and agriculture
5. Chicken genome analysis unlocks secrets of mammalian and bird evolution
6. Chicken genomic sequence yields insight into vertebrate evolution
7. Unravelling new complexity in the genome
8. One species, many genomes
9. First genome-wide study of infectious disease opens new avenues for HIV treatment, vaccines
10. Charting ever-changing genomes
11. Neutral evolution has helped shape our genome

Post Your Comments:
(Date:10/30/2014)... therapeutics present unique challenges when it comes to ... harm. New consensus guidelines for toxicity testing that ... characteristics of these novel biopharmaceuticals are presented in ... from Mary Ann Liebert, Inc. publishers . ... Nucleic Acid Therapeutics website until November 30, ...
(Date:10/30/2014)... Oct. 29, 2014  Securus Technologies, a ... technology solutions for public safety, investigation, corrections ... deployed exciting enhancements to its THREADS™ product, ... provide actionable intelligence and focused leads for ... drive technological innovation through identifying and delivering ...
(Date:10/29/2014)... Beaverton, OR) New research presented at the ... in Houston, TX showed for the first time ... in women using a readily available nutritional supplement, ... by Dr. Judith A. Smith, Pharm.D., associate professor ... Sciences at The University of Texas Health Science ...
Breaking Biology News(10 mins):New guidelines for reproductive & developmental toxicity testing of oligonucleotide drugs 2Securus Technologies Adds Advanced Features to Its Industry-Leading Investigative Analytics Product 2HPV infections in women eradicated by AHCC, Japanese mushroom extract 2
(Date:10/30/2014)... , Oct. 30, 2014  Regado Biosciences, Inc. ... will hold a conference call and live audio webcast ... to discuss its third quarter 2014 financial results. ... call by dialing (888) 347-1165 for domestic callers or ... be webcast live under the investor relations section of ...
(Date:10/30/2014)... (Oct. 29, 2014) – The severe flooding that devastated ... been less destructive if the bridges, roads and other ... new study from the University of Colorado Denver. , ... infrastructure," said Jimmy Kim, PhD, associate professor of structural ... Applied Science and lead author the study. "There is ...
(Date:10/27/2014)... October 27, 2014 The new ... Type (High & Medium), Sub-type (Primary & Secondary), ... Infrastructure & Transportation & Power Generation) - Trends ... GIS market with analysis and forecasting of the ... Data Tables with 52 Figures spread through 146 ...
(Date:10/27/2014)... TORONTO , Oct. 27, 2014 ... (OTCQB: GNBT) today announced two presentations demonstrating that ... its novel proprietary cancer immunotherapeutic AE37 vaccine correlated ... patients. The AE37 cancer vaccine is being developed ... ( www.antigenexpress.com ). The presentations are being made ...
Breaking Biology Technology:Regado Biosciences to Provide Third Quarter 2014 Financial Results 2CU Denver study says upgrading infrastructure could reduce flood damage 2Gas Insulated Switchgear Market worth $21,951.9 Million by 2019 - New Report by MarketsandMarkets 2Gas Insulated Switchgear Market worth $21,951.9 Million by 2019 - New Report by MarketsandMarkets 3Gas Insulated Switchgear Market worth $21,951.9 Million by 2019 - New Report by MarketsandMarkets 4Generex Announces Presentations Correlating Immunological Response with Reduced Recurrence in Phase II Study of AE37 Breast Cancer Vaccine in Patients at the American College of Surgeons 2Generex Announces Presentations Correlating Immunological Response with Reduced Recurrence in Phase II Study of AE37 Breast Cancer Vaccine in Patients at the American College of Surgeons 3Generex Announces Presentations Correlating Immunological Response with Reduced Recurrence in Phase II Study of AE37 Breast Cancer Vaccine in Patients at the American College of Surgeons 4
Cached News: